Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on July 24, 2007
JNCI Journal of the National Cancer Institute 2007 99(15):1148-1150; doi:10.1093/jnci/djm097
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
99/15/1148    most recent
djm097v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Miller, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, J. D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2007.

NEWS

Study Affirms Pharma's Influence on Physicians

John Dudley Miller

The first 150 words of the full text of this article appear below.

Physicians are under more intense financial pressure than ever to prescribe pharmaceutical manufacturers’ expensive new drugs even when cheaper, more established drugs may be at least as effective. Coupled with psychological or social pressure that may distort a doctor's judgment, the influence of free gifts and subtle economic incentives may have financial costs, according to several recent studies on the interactions between doctors and drug company representatives.

In 2004, pharmaceutical companies spent an average of $10,000 per practicing American physician on free meals, free continuing medical education (CME) training, free trips to conferences, and payments for various services, according to data compiled by IMS Health, a company monitoring the industry's finances. Those drug representatives also gave the average doctor an extra $21,000 in free drug samples. The total 2004 tab for drug representative strategies: $23.7 billion.

That's twice as much money as drug manufacturers spent influencing physicians just 6 years . . . [Full Text of this Article]

Why Drug Reps Court Doctors

Company Culture


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?